Showing 261-270 of 19172 results for "".
Prova Education -- Improving Treatment for Type 2 Diabetes: Overcoming Barriers to Optimal Care, Part 1
https://reachmd.com/programs/grand-rounds-nation/prova-education-improving-treatment-for-type-2-diabetes-overcoming-barriers-to-optimal-care-part-1/6564/This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems oUpdates in the Classification & Diagnosis of Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/updates-in-the-classification-diagnosis-of-type-2-diabetes/6641/Host Dr. Farhad Zangeneh welcomes Dr. Kathleen "Kittie" Wyne from the The Methodist Hospital Research Institute (TMHRI) in Houston where she also coordinates their clinical research program in The Diabetes Research Center. Dr. Wyne discusses the changing classification of diabetes and pre-diabetes aNovel Treatments for Diabetes
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/novel-treatments-for-diabetes/1787/Dr. Lazar discusses exciting new innovations in our approach to both type I and type II diabetes including Islet cell transplantation, medications for beta cell preservation and new insights into the control of obesity.Diabetic Retinopathy I
https://reachmd.com/programs/revealing-retina/diabetic-retinopathy-i/1727/Tune in to hear the first in a monthly series entitled, "The Revealing Retina". Dr. Roy Levit, host and president of the American Retina Fundation, welcomes Dr. Suber Huang, Director of Vitreoretinal Diseases and Surgery at University Hospitals of Cleveland, and Medical Director and Treasurer for UnThe Case for Pancreas-After-Kidney Transplantation in Type 1 Diabetics
https://reachmd.com/programs/advances-in-transplantation/the-case-for-pancreas-after-kidney-transplantation-in-type-1-diabetics/6379/Although most patients with type 1 diabetes are able to rely on insulin to effectively manage their condition, sometimes insulin is not enough. When should these patients consider pancreas and/or kidney transplant? Dr. Jonathan Fridell, surgical director of the pancreas transplant program at IndianaDiabetic Retinopathy: Types, Causes, and Associated Somatic Changes
https://reachmd.com/programs/revealing-retina/diabetic-retinopathy-types-causes-and-associated-somatic-changes/5625/The eyes can yield clues to vascular issues elsewhere in the body. How can the two forms of diabetic retinopathy, which are non-proliferative and proliferative, affect vision, and how might retinopathy be associated with somatic effects resulting from diabetes? Dr. Alan Ruby, opthamologist and cliniRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
https://reachmd.com/programs/eye-on-ocular-health/risk-of-rvo-in-type-2-diabetes-glp-1-receptor-agonists-versus-dpp-4-inhibitors/37663/Among patients with type 2 diabetes, retinal vein occlusion (RVO) is a significant clinical challenge, as well as a leading cause of irreversible vision loss. With vascular health at the center of diabetes management, the choice of glucose-lowering therapy may influence ocular outcomes. Join Dr. MimGastric Banding for Remission of Type 2 Diabetes
https://reachmd.com/programs/focus-on-diabetes/gastric-banding-for-remission-of-type-2-diabetes/3823/There is mounting evidence that surgery can be a key weapon against diabetes, improving glycemic control or sending the disease into remission entirely. As the scourge of diabetes continues across our country and abroad, safety and efficacy of surgery are two legitimate concerns. How does gastric baFinerenone for CKD in Type 1 Diabetes: Updates from FINE-ONE
https://reachmd.com/programs/heart-matters/finerenone-ckd-type-1-diabetes-fine-one/35909/Chronic kidney disease (CKD) is a serious and under-addressed complication in people with type 1 diabetes. However, after limited advancements in treatment for over three decades, the FINE-ONE trial has found positive results for the use of finerenone in this patient population. Join Dr. Janet McGilCatering Drug Therapies To Specific Subsets of Patients with Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/catering-drug-therapies-to-specific-subsets-of-patients-with-type-2-diabetes/6387/Treatment regimens for diabetes and obesity are merging. Healthcare professionals are taking a new view to the management of diabetes including rearranging diabetes medication regimens from a glucose control and weight-neutral perspective. What do healthcare professionals need to know to help their